These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 25889218)

  • 1. The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity.
    Akolkar G; Bhullar N; Bews H; Shaikh B; Premecz S; Bordun KA; Cheung DY; Goyal V; Sharma AK; Garber P; Singal PK; Jassal DS
    Cardiovasc Ultrasound; 2015 Apr; 13():18. PubMed ID: 25889218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
    Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
    Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.
    Mozolevska V; Schwartz A; Cheung D; Goyal V; Shaikh B; Dingman B; Kim E; Mittal I; Asselin CY; Edel A; Ravandi A; Thliveris J; Singal PK; Czaykowski P; Jassal DS
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H446-H458. PubMed ID: 30499710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and trastuzumab regimen induces biventricular failure in mice.
    Milano G; Raucci A; Scopece A; Daniele R; Guerrini U; Sironi L; Cardinale D; Capogrossi MC; Pompilio G
    J Am Soc Echocardiogr; 2014 May; 27(5):568-79. PubMed ID: 24534652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
    Eekhoudt CR; Bortoluzzi T; Varghese SS; Cheung DYC; Christie S; Eastman S; Mittal I; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Jassal DS
    Curr Oncol; 2022 Apr; 29(5):2941-2953. PubMed ID: 35621631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardioprotective role of probucol against anthracycline and trastuzumab-mediated cardiotoxicity.
    Walker JR; Sharma A; Lytwyn M; Bohonis S; Thliveris J; Singal PK; Jassal DS
    J Am Soc Echocardiogr; 2011 Jun; 24(6):699-705. PubMed ID: 21353471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
    Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
    Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
    Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
    Milano G; Biemmi V; Lazzarini E; Balbi C; Ciullo A; Bolis S; Ameri P; Di Silvestre D; Mauri P; Barile L; Vassalli G
    Cardiovasc Res; 2020 Feb; 116(2):383-392. PubMed ID: 31098627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of renin-angiotensin inhibitors and β-blockers in trastuzumab-related cardiotoxicity.
    Ohtani K; Ide T; Hiasa KI; Sakamoto I; Yamashita N; Kubo M; Tsutsui H
    Clin Res Cardiol; 2019 Oct; 108(10):1128-1139. PubMed ID: 30859381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.
    Pituskin E; Mackey JR; Koshman S; Jassal D; Pitz M; Haykowsky MJ; Pagano JJ; Chow K; Thompson RB; Vos LJ; Ghosh S; Oudit GY; Ezekowitz JA; Paterson DI
    J Clin Oncol; 2017 Mar; 35(8):870-877. PubMed ID: 27893331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
    Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
    J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catching broken hearts: pre-clinical detection of doxorubicin and trastuzumab mediated cardiac dysfunction in the breast cancer setting.
    Saeed MF; Premecz S; Goyal V; Singal PK; Jassal DS
    Can J Physiol Pharmacol; 2014 Jul; 92(7):546-50. PubMed ID: 24959994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
    Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
    Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
    Thomas CM; Yong QC; Seqqat R; Chandel N; Feldman DL; Baker KM; Kumar R
    Clin Sci (Lond); 2013 Apr; 124(8):529-41. PubMed ID: 23116220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.
    Guglin M; Munster P; Fink A; Krischer J
    Am Heart J; 2017 Jun; 188():87-92. PubMed ID: 28577685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small benefits in trastuzumab-related cardiotoxicity.
    Das M
    Lancet Oncol; 2017 Jan; 18(1):e5. PubMed ID: 27956153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.